Debbie Schultz actually said...

"It is past time that we take back the power that we surrendered."

"This committee's investigation shines a spotlight on the ways that drug companies use litigation as a key part of their strategic plans to delay generic entry."

"As a breast cancer survivor, the high cost of cancer treatment is very personal to me."

"Prevention of generic encroachment just means to delay generic competition."